{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:35:59Z","timestamp":1791909359469,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T00:00:00Z","timestamp":1366588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T00:00:00Z","timestamp":1366588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/leu.2013.124","type":"journal-article","created":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T02:38:20Z","timestamp":1366598300000},"page":"166-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Multiparameter flow cytometry for the identification of the Waldenstr\u00f6m\u2019s clone in IgM-MGUS and Waldenstr\u00f6m\u2019s Macroglobulinemia: new criteria for differential diagnosis and risk stratification"],"prefix":"10.1038","volume":"28","author":[{"given":"B","family":"Paiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M","family":"Ocio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"de las Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Cuello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"de Coca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Galende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Pardal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"B\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T J","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-B","family":"Vidr\u00edales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J F","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,22]]},"reference":[{"key":"BFleu2013124_CR1","volume-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"S Swerdlow","year":"2008","unstructured":"Swerdlow S, Campos E, Harris N, Jaffe E, Pileri S, Stein H et al WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. IARC: Lyon, 2008."},{"key":"BFleu2013124_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/sonc.2003.50082","volume":"30","author":"RG Owen","year":"2003","unstructured":"Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML et al. Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003; 30: 110\u2013115.","journal-title":"Semin Oncol"},{"key":"BFleu2013124_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ajh.23192","volume":"87","author":"MA Gertz","year":"2012","unstructured":"Gertz MA . Waldenstrom macroglobulinemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012; 87: 503\u2013510.","journal-title":"Am J Hematol"},{"key":"BFleu2013124_CR4","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1182\/blood-2011-10-384768","volume":"119","author":"RA Kyle","year":"2012","unstructured":"Kyle RA, Benson JT, Larson DR, Therneau TM, Dispenzieri A, Kumar S et al. Progression in smoldering Waldenstrom macroglobulinemia: long-term results. Blood 2012; 119: 4462\u20134466.","journal-title":"Blood"},{"key":"BFleu2013124_CR5","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1182\/blood-2003-03-0801","volume":"102","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR et al. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003; 102: 3759\u20133764.","journal-title":"Blood"},{"key":"BFleu2013124_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/leu.2008.291","volume":"23","author":"RA Kyle","year":"2009","unstructured":"Kyle RA, Rajkumar SV . Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23: 3\u20139.","journal-title":"Leukemia"},{"key":"BFleu2013124_CR7","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","volume":"113","author":"BM Weiss","year":"2009","unstructured":"Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM . A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 2009; 113: 5418\u20135422.","journal-title":"Blood"},{"key":"BFleu2013124_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3816\/CLM.2009.n.002","volume":"9","author":"RA Kyle","year":"2009","unstructured":"Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton Iii LJ et al. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenstrom\u2019s macroglobulinemia. Clin Lymphoma Myeloma Leuk 2009; 9: 17\u201318.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"BFleu2013124_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564\u2013569.","journal-title":"N Engl J Med"},{"key":"BFleu2013124_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1365-2141.2007.06845.x","volume":"139","author":"ML McMaster","year":"2007","unstructured":"McMaster ML, Caporaso N . Waldenstrom macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. Br J Haematol 2007; 139: 663\u2013671.","journal-title":"Br J Haematol"},{"key":"BFleu2013124_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cancergencyto.2006.04.009","volume":"169","author":"RF Schop","year":"2006","unstructured":"Schop RF, Van Wier SA, Xu R, Ghobrial I, Ahmann GJ, Greipp PR et al. 6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance. Cancer Genet Cytogenet 2006; 169: 150\u2013153.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFleu2013124_CR12","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1200\/JCO.2005.06.147","volume":"23","author":"L Baldini","year":"2005","unstructured":"Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, Rossi A et al. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system. J Clin Oncol 2005; 23: 4662\u20134668.","journal-title":"J Clin Oncol"},{"key":"BFleu2013124_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1200\/JCO.2000.18.1.214","volume":"18","author":"MA Dimopoulos","year":"2000","unstructured":"Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M . Waldenstrom's macroglobulinemia: clinical features, complications, and management. J Clin Oncol 2000; 18: 214\u2013226.","journal-title":"J Clin Oncol"},{"key":"BFleu2013124_CR14","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/leu.2012.121","volume":"26","author":"JJ van Dongen","year":"2012","unstructured":"van Dongen JJ, Orfao A . EuroFlow: resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine. Leukemia 2012; 26: 1899\u20131907.","journal-title":"Leukemia"},{"key":"BFleu2013124_CR15","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","volume":"110","author":"E Perez-Persona","year":"2007","unstructured":"Perez-Persona E, Vidriales MB, Mateo G, Garcia-Sanz R, Mateos MV, de Coca AG et al. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. Blood 2007; 110: 2586\u20132592.","journal-title":"Blood"},{"key":"BFleu2013124_CR16","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1182\/blood-2009-05-221689","volume":"114","author":"B Paiva","year":"2009","unstructured":"Paiva B, Vidriales MB, Mateo G, Perez JJ, Montalban MA, Sureda A et al. The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients. Blood 2009; 114: 4369\u20134372.","journal-title":"Blood"},{"key":"BFleu2013124_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/sonc.2003.50074","volume":"30","author":"JF San Miguel","year":"2003","unstructured":"San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sanchez-Guijo F, Sanchez ML et al. Immunophenotypic analysis of Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30: 187\u2013195.","journal-title":"Semin Oncol"},{"key":"BFleu2013124_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3816\/CLM.2005.n.007","volume":"5","author":"EM Ocio","year":"2005","unstructured":"Ocio EM, Hernandez JM, Mateo G, Sanchez ML, Gonzalez B, Vidriales B et al. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma. Clin Lymphoma 2005; 5: 241\u2013245.","journal-title":"Clin Lymphoma"},{"key":"BFleu2013124_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3816\/CLML.2011.n.018","volume":"11","author":"MT Howard","year":"2011","unstructured":"Howard MT, Hodnefield J, Morice WG . Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma\/Waldenstrom\u2019s macroglobulinemia is comparable to flow cytometric techniques. Clin Lymphoma Myeloma Leuk 2011; 11: 96\u201398.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"BFleu2013124_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1309\/3G1XDX0DVHBNVKB4","volume":"124","author":"S Konoplev","year":"2005","unstructured":"Konoplev S, Medeiros LJ, Bueso-Ramos CE, Jorgensen JL, Lin P . Immunophenotypic profile of lymphoplasmacytic lymphoma\/Waldenstrom macroglobulinemia. Am J Clin Pathol 2005; 124: 414\u2013420.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2013124_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1600-0609.2010.01503.x","volume":"85","author":"M Merli","year":"2010","unstructured":"Merli M, Arcaini L, Boveri E, Rattotti S, Picone C, Passamonti F et al. Assessment of bone marrow involvement in non-Hodgkin\u2019s lymphomas: comparison between histology and flow cytometry. Eur J Haematol 2010; 85: 405\u2013415.","journal-title":"Eur J Haematol"},{"key":"BFleu2013124_CR22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/modpathol.2009.34","volume":"22","author":"WG Morice","year":"2009","unstructured":"Morice WG, Chen D, Kurtin PJ, Hanson CA, McPhail ED . Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom's macroglobulinemia. Mod Pathol 2009; 22: 807\u2013816.","journal-title":"Mod Pathol"},{"key":"BFleu2013124_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1053\/sonc.2003.50073","volume":"30","author":"ED Remstein","year":"2003","unstructured":"Remstein ED, Hanson CA, Kyle RA, Hodnefield JM, Kurtin PJ . Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom\u2019s macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells. Semin Oncol 2003; 30: 182\u2013186.","journal-title":"Semin Oncol"},{"key":"BFleu2013124_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/sonc.2003.50038","volume":"30","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Treon SP, Alexanian R, Barlogie B, Bjorkholm M, Dhodapkar M et al. Prognostic markers and criteria to initiate therapy in Waldenstrom\u2019s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia. Semin Oncol 2003; 30: 116\u2013120.","journal-title":"Semin Oncol"},{"key":"BFleu2013124_CR25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1056\/NEJMoa1200710","volume":"367","author":"SP Treon","year":"2012","unstructured":"Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl J Med 2012; 367: 826\u2013833.","journal-title":"N Engl J Med"},{"key":"BFleu2013124_CR26","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","volume":"117","author":"M Dimopoulos","year":"2011","unstructured":"Dimopoulos M, Kyle R, Fermand JP, Rajkumar SV, San Miguel J, Chanan-Khan A et al. Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood 2011; 117: 4701\u20134705.","journal-title":"Blood"},{"key":"BFleu2013124_CR27","first-page":"1655","volume":"152","author":"M Ocqueteau","year":"1998","unstructured":"Ocqueteau M, Orfao A, Almeida J, Blade J, Gonzalez M, Garcia-Sanz R et al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol 1998; 152: 1655\u20131665.","journal-title":"Am J Pathol"},{"key":"BFleu2013124_CR28","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMc1211959","volume":"367","author":"O Landgren","year":"2012","unstructured":"Landgren O, Staudt L . MYD88 L265P somatic mutation in IgM MGUS. N Engl J Med 2012; 367: 2255\u20132257.","journal-title":"N Engl J Med"},{"key":"BFleu2013124_CR29","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","volume":"121","author":"M Varettoni","year":"2013","unstructured":"Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstr\u00f6m's macroglobulinemia and related lymphoid neoplasms. Blood 2013; 121: 2522\u20132528.","journal-title":"Blood"},{"key":"BFleu2013124_CR30","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","volume":"121","author":"L Xu","year":"2013","unstructured":"Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X et al. MYD88 L265P in Waldenstr\u00f6m's macroglobulinemia, IgM monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific PCR. Blood 2013; 121: 2051\u20132058.","journal-title":"Blood"},{"key":"BFleu2013124_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/j.1365-2141.2001.03144.x","volume":"115","author":"R Garcia-Sanz","year":"2001","unstructured":"Garcia-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A et al. Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br J Haematol 2001; 115: 575\u2013582.","journal-title":"Br J Haematol"},{"key":"BFleu2013124_CR32","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","volume":"113","author":"P Morel","year":"2009","unstructured":"Morel P, Duhamel A, Gobbi P, Dimopoulos MA, Dhodapkar MV, McCoy J et al. International prognostic scoring system for Waldenstrom macroglobulinemia. Blood 2009; 113: 4163\u20134170.","journal-title":"Blood"},{"key":"BFleu2013124_CR33","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1182\/blood-2010-12-324665","volume":"117","author":"B Paiva","year":"2011","unstructured":"Paiva B, Vidriales MB, Perez JJ, Lopez-Berges MC, Garcia-Sanz R, Ocio EM et al. The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis. Blood 2011; 117: 3613\u20133616.","journal-title":"Blood"},{"key":"BFleu2013124_CR34","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1182\/blood-2006-07-037077","volume":"109","author":"F Zhan","year":"2007","unstructured":"Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, Hollmig K et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 2007; 109: 1692\u20131700.","journal-title":"Blood"},{"key":"BFleu2013124_CR35","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/leu.2012.296","volume":"27","author":"JT Larsen","year":"2012","unstructured":"Larsen JT, Kumar SK, Dispenzieri A, Kyle RA, Katzmann JA, Rajkumar SV . Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma. Leukemia 2012; 27: 941\u2013946.","journal-title":"Leukemia"},{"key":"BFleu2013124_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/leu.2012.189","volume":"27","author":"JA Katzmann","year":"2012","unstructured":"Katzmann JA, Clark R, Kyle RA, Larson DR, Therneau TM, Melton LJ 3rd et al. Suppression of uninvolved immunoglobulins defined by heavy\/light chain pair suppression is a risk factor for progression of MGUS. Leukemia 2012; 27: 208\u2013212.","journal-title":"Leukemia"},{"key":"BFleu2013124_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011; 470: 115\u2013119.","journal-title":"Nature"},{"key":"BFleu2013124_CR38","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ng.892","volume":"43","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Trifonov V, Fabbri G . Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43: 830\u2013837.","journal-title":"Nat Genet"},{"key":"BFleu2013124_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"470","author":"X Puente","year":"2011","unstructured":"Puente X, Pinol M, Quesada V . Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 470: 101\u2013105.","journal-title":"Nature"},{"issue":"Suppl 1","key":"BFleu2013124_CR40","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/cyto.b.20547","volume":"78","author":"M Perez-Andres","year":"2010","unstructured":"Perez-Andres M, Paiva B, Nieto WG, Caraux A, Schmitz A, Almeida J et al. Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. Cytometry B Clin Cytom 2010; 78 (Suppl 1): S47\u2013S60.","journal-title":"Cytometry B Clin Cytom"},{"issue":"8","key":"BFleu2013124_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ajh.22061","volume":"86","author":"Roger G Owen","year":"2011","unstructured":"Owen R, Feyler S, O'Connor S, Bond L, De Tute R, Rawstron A . Defining IgM multiple myeloma. Am J Hematol 2011, 717.","journal-title":"American Journal of Hematology"},{"key":"BFleu2013124_CR42","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/jcp.2010.088591","volume":"64","author":"SR Pasricha","year":"2011","unstructured":"Pasricha SR, Juneja SK, Westerman DA, Came NA . Bone-marrow plasma cell burden correlates with IgM paraprotein concentration in Waldenstrom macroglobulinaemia. J Clin Pathol 2011; 64: 520\u2013523.","journal-title":"J Clin Pathol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2013124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013124","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:30:06Z","timestamp":1648726206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2013124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,22]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFleu2013124"],"URL":"https:\/\/doi.org\/10.1038\/leu.2013.124","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718002168.793540223","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,22]]},"assertion":[{"value":"12 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}